Delivery Order SPE2DB20D3101-SPE2DB24FRUT5

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $10,903.62, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used to manage diabetes. This is a firm fixed-price Delivery Order contract with a completion date of December 19, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $2,757.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a diabetes medication. This is a delivery order contract with a firm fixed price, and the ultimate completion date is July 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $5,927.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. This is a firm-fixed-price delivery order contract with a completion date of July 24, 2023. The contract is not associated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, with a ceiling value of $10,109.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a diabetes medication, to support military and government healthcare programs. This is a firm fixed-price delivery order contract with a performance period extending to May 2025. The contract is not set-aside and was awarded through open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trulicity 3 mg/0.5 ml pens. The $13,289.22 firm fixed price delivery order has a completion date of September 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of...
This federal contract award, valued at $7,481.92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Trulicity 1.5 mg/0.5 ml pens, a prescription medication used to manage diabetes. This contract is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,015.98, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used to manage diabetes. This is a delivery order contract with a firm fixed price pricing type, with a completion date of July 19, 2024. The contract was not set aside for any specific business categories....
This federal contract award, valued at $17,378.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication commonly used to treat diabetes. The contract has an ultimate completion date of November 18, 2024 and is priced on a Firm Fixed Price basis. The contract is not designated with a set-aside...
This federal contract award, valued at $1,741.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used to manage diabetes. The contract does not have a set-aside designation, indicating open competition. It is a delivery order contract with a firm fixed price pricing type, with a final completion date of July 9,...
This federal contract award, valued at $8,979.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used for the treatment of diabetes. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRUT5
    Delivery Order

This federal contract award, valued at $11,611.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 3 mg/0.5 ml pens, a medication used to manage diabetes. This is a firm fixed-price delivery order contract with a completion date of September 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 11:28 AM